Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CADASIL Disease Discovery

NCT02821780 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT02821780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02821780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CADASIL Disease Discovery
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
October 18, 2016
Completion date
May 3, 2022
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arterial stiffness, cardiovascular disease, clinical phenotype of cadasil, germline mutation in the notch 3 gene, pathogenesis of cadasil